Background: Tuberculosis is an air-borne contagious disease caused by slow-growing Mycobacterium tuberculosis (Mtb). According to Global Tuberculosis Report 2022, 1.6 million people were infected by tuberculosis in 2021. The continuing spread of drug-resistant tuberculosis (TB) is one of the most difficult challenges to control the tuberculosis. So new drug discovery is essential to the treatment of tuberculosis. This study aims to develop a QSAR model to predict the antitubercular activity of tetrahydronaphthalene derivatives. The QSARINS was used in this study to develop the QSAR predictive model. Results: A number of tetrahydronaphthalene derivatives with MIC90 values were obtained from the literature to develop the QSAR predictive model. The compounds were divided into two sets: a training set consisting of 39 compounds and a test set containing 13 compounds. The best predictive Model 4 has R2: 0.8303, Q2LOO: 0.7642, LOF: 0.0550, Q2-F1: 0.7190, Q2-F2: 0.7067, Q2-F3: 0.7938 and CCCext: 0.8720. Based on the developed QSAR equation, the new compounds were designed and subjected to molecular docking, molecular dynamics and ADMET analysis. Conclusion: In the QSAR model, the molecular descriptors of MATS8s, Chi4, bcutv8, Petitjeant and fr_aniline were highly influenced the antitubercular activity. The developed QSAR model helps to predict the antitubercular activity of tetrahydronaphthalene derivatives.
The rapid emergence of antimicrobial resistance demands the discovery of new antibacterial targets and inhibitors. Staphylococcus aureus filamenting temperature-sensitive protein (SaFtsZ), an essential cytoskeletal protein involved in bacterial cytokinesis and Z-ring formation, has gained attention as a promising target for antibacterial drug discovery. In the present study, an integrated computational strategy involving pharmacophore mapping, molecular docking, molecular dynamics (MD) simulations, and density functional theory (DFT) analysis was employed to identify potential SaFtsZ inhibitors. Initially, large compound library was screened from the Pharmit database using a structure-based pharmacophore model to identify molecules with key interaction features required for SaFtsZ inhibition. The selected 200 candidates were further evaluated through molecular docking to determine their binding affinity and interaction pattern within the active site of SaFtsZ. Among the screened molecules, compound 15 (CID 135468497) exhibited the highest binding affinity with a docking score of -10.8 kcal mol-1. Subsequent MD simulation confirmed the stability of the protein-ligand complex, while DFT analysis provided insights into the electronic characteristics and reactivity of compound 15. These findings highlight compound 15 as a computationally predicted scaffold for the development of SaFtsZ-targeted antibacterial agents. However, experimental validation is required to confirm the computational results.
Alzheimer's disease (AD) is a progressive neurological condition marked by cognitive deterioration and restricted treatment alternatives. This study investigated Bacopa monnieri , a traditional medicinal herb recognized for its neuroprotective characteristics, to assess its therapeutic potential against Alzheimer's disease by in silico methods. A network pharmacology approach was utilized to discover targets related to Alzheimer's disease, with CASP3 and APP identified as pivotal nodes. Molecular docking study revealed that three phytochemicals—Luteolin, Apigenin, displayed significant binding affinities for these targets. Moreover, molecular dynamics (MD) simulations confirmed the stability of the ligand–protein interactions throughout time, affirming advantageous conformational behavior. The ADMET study demonstrated satisfactory pharmacokinetic and drug‐likeness characteristics for the phytoconstituents. The results indicate that phytochemicals from B. monnieri , specifically Luteolin and Apigenin, exhibit promise as lead molecules for additional research and development in Alzheimer's disease therapies. Using cutting‐edge computational tools, this study was planned as a thorough in silico investigation that would effectively screen and analyze phytoconstituents and their molecular targets. The results provide a solid basis for upcoming in vitro and in vivo validations, even though the current phase concentrates on computational techniques.